Cargando…

Juvenile idiopathic arthritis is a diagnosis of exclusion

Detalles Bibliográficos
Autores principales:	Alexeeva, Ekaterina, Denisova, Rina, Valieva, Sanya, Bzarova, Tatyana, Isayeva, Ksenya, Sleptsova, Tatyana, Chistyakova, Evgeniya, Fetisova, Anna, Lomakina, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191287/ http://dx.doi.org/10.1186/1546-0096-12-S1-P224

Ejemplares similares

Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Quality of life in patients with juvenile arthritis: adalimumab might make a difference
por: Denisova, Rina, et al.
Publicado: (2011)

PReS-FINAL-2041: Macrophage activation syndrome in the children with systemic juvenile idiopathic arthritis during the course of tocilizumab
por: Alekseeva, E, et al.
Publicado: (2013)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
por: Alexeeva, E, et al.
Publicado: (2011)

Early treatment with infliximab in patients with juvenile idiopathic arthritis
por: Sleptsova, TV, et al.
Publicado: (2011)

Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data
por: Alexeeva, Ekaterina, et al.
Publicado: (2023)

Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia
por: Alexeeva, Ekaterina I., et al.
Publicado: (2017)

P02-029 - CAPS or SJIA
por: Alekseeva, E, et al.
Publicado: (2013)

P02-011 - TRAPS syndrome debuted as systemic JIA
por: Sleptsova, T, et al.
Publicado: (2013)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
por: Katargina, LA, et al.
Publicado: (2011)

Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2014)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

Juvenile idiopathic arthritis classification
por: Martini, Alberto
Publicado: (2014)

Juvenile idiopathic arthritis—recent advances
por: Rosendahl, Karen
Publicado: (2011)

Juvenile idiopathic arthritis: the transition to adulthood
por: Fernandes, Susana, et al.
Publicado: (2014)

Clinical and psychological status of patients with different types of juvenile arthritis
por: Stepanenko, Natalia, et al.
Publicado: (2014)

Juvenile idiopathic arthritis with systemic onset with inflammatory bone lesions: two case reports of patients successfully treated with canakinumab and experience gained from literature
por: Alexeeva, Ekaterina I., et al.
Publicado: (2023)

Clinical and articular presentation of juvenile idiopathic arthritis
por: Ravichandran, R, et al.
Publicado: (2008)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

Depression, anxiety and pain in juvenile idiopathic arthritis
por: Erdogdu, D, et al.
Publicado: (2008)

Illness representation in adolescents with juvenile idiopathic arthritis
por: Lelieveld, OTHM, et al.
Publicado: (2008)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Systemic juvenile idiopathic arthritis in the republic of Bashkortostan
por: Malievskiy, VA
Publicado: (2011)

Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis
por: Schou, AJ, et al.
Publicado: (2011)

TH17-phenotypes of juvenile idiopathic arthritis
por: Turtsevich, Inga Z, et al.
Publicado: (2014)

Methotrexate in oligoarticular persistent juvenile idiopathic arthritis
por: Horneff, Gerd, et al.
Publicado: (2014)

Juvenile idiopathic arthritis treated with biological therapies
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
por: Horneff, G, et al.
Publicado: (2015)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

Early untreated juvenile idiopathic arthritis: predictors of outcome
por: Pascoli, L, et al.
Publicado: (2008)

Temporomandibular joint involvement in children with juvenile idiopathic arthritis
por: Cannizzaro, E, et al.
Publicado: (2008)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
por: Zak, M, et al.
Publicado: (2008)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
por: Heijstek, MW, et al.
Publicado: (2008)

Genetic markers in clinical subtypes of juvenile idiopathic arthritis
por: Le Blay, Pierre, et al.
Publicado: (2011)

Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
por: Lazareva, Arina, et al.
Publicado: (2011)

Coeliac disease and intestinal inflammation in juvenil idiopathic arthritis
por: Nuñez, Esmeralda, et al.
Publicado: (2011)

Genetic susceptibility to juvenile idiopathic arthritis in Iranian children
por: Shiari, Reza, et al.
Publicado: (2011)

MRI evaluation of clinical remission in juvenile idiopathic arthritis
por: van Veenendaal, M, et al.
Publicado: (2011)

Impact of biologics on growth in children with juvenile idiopathic arthritis
por: Uettwiller, F, et al.
Publicado: (2011)

Intra-articular corticosteroid injections in juvenile idiopathic arthritis
por: Carrasco, Roberto, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qvpd9msfc9fb45oc43nkaeuoc8